High-dose combination chemotherapy with cyclophosphamide, carmustine, etoposide, and autologous bone marrow transplantation in 60 patients with relapsed Hodgkin's disease: the M. D. Anderson experience

Recent Results Cancer Res. 1989:117:233-8. doi: 10.1007/978-3-642-83781-4_25.
No abstract available

MeSH terms

  • Adolescent
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bone Marrow Transplantation* / adverse effects
  • Carmustine / administration & dosage
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Etoposide / administration & dosage
  • Female
  • Hodgkin Disease / drug therapy
  • Hodgkin Disease / surgery
  • Hodgkin Disease / therapy*
  • Humans
  • Male
  • Middle Aged

Substances

  • Etoposide
  • Cyclophosphamide
  • Carmustine

Supplementary concepts

  • CBV protocol